Assessment of APOE in atypical parkinsonism syndromes
- 1 July 2019
- journal article
- research article
- Published by Elsevier in Neurobiology of Disease
- Vol. 127, 142-146
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
This publication has 50 references indexed in Scilit:
- Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapyNature Reviews Neurology, 2013
- A large study reveals no association between APOE and Parkinson's diseaseNeurobiology of Disease, 2012
- Identification of common variants influencing risk of the tauopathy progressive supranuclear palsyNature Genetics, 2011
- Second consensus statement on the diagnosis of multiple system atrophyNeurology, 2008
- The quest for genetic determinants of human longevity: challenges and insightsNature Reviews Genetics, 2006
- Apolipoprotein E ϵ4 Allele Has No Effect on Age at Onset or Duration of Disease in Cases of Frontotemporal Dementia with Pick- or Microvacuolar-Type HistologyExperimental Neurology, 2000
- Apolipoprotein E ϵ4 allele frequency in patients with Lewy body dementia, Alzheimer's disease and age-matched controlsNeuroscience Letters, 1994
- Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer diseaseNature Genetics, 1994
- Genetic associations with human longevity at the APOE and ACE lociNature Genetics, 1994
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993